Search Results
Found 1 results
510(k) Data Aggregation
(88 days)
The proposed device will have the following indications: prevention and retardation of muscle disuse atrophy, increase local blood flow, increase range of motion, prevent venous thrombosis with immediate postsurgical stimulation of calf muscles; relaxation of muscle spasms.
Not Found
The provided document is a 510(k) premarket notification letter from the FDA regarding the MSI Magna-Stym device. It states that the device has been found substantially equivalent to a predicate device and can be marketed.
However, the document does not contain any information about:
- Acceptance criteria table or reported device performance metrics.
- The study design, sample sizes, data provenance, number or qualifications of experts, or ground truth establishment for either test or training sets.
- Whether a multi-reader, multi-case (MRMC) comparative effectiveness study or a standalone algorithm performance study was done.
Therefore, I cannot provide the requested information based on the given text. The document is solely a regulatory letter of approval, not a technical study report.
Ask a specific question about this device
Page 1 of 1